
0:00
26:16
Dr. Venkat Katapatna breaks down the newly adopted MASLD nomenclature and its implications for diagnosing and managing metabolic dysfunction–associated steatotic liver disease. He highlights updated AASLD guidelines, the expanding role of advanced imaging, and how radiologists are central to early detection, treatment selection, and longitudinal disease monitoring.
Więcej odcinków z kanału "RadioGraphics Podcast | RSNA"



Nie przegap odcinka z kanału “RadioGraphics Podcast | RSNA”! Subskrybuj bezpłatnie w aplikacji GetPodcast.







